Aprea Therapeutics Appoints John Hamill as Chief Financial Officer

Go back to Aprea Therapeutics Appoints John Hamill as Chief Financial Officer
Aperture Health, Inc. (NASDAQ: APRE) Delayed: 0.68 +0.02 (3.03%)
Previous Close $0.66    52 Week High $0.08 
Open $0.78    52 Week Low $0.00 
Day High $0.78    P/E N/A 
Day Low $0.66    EPS $0.00 
Volume 28,224